Mey Capital Matrix is a venture capital firm headquartered in Munich, Germany, focusing on investments in the life sciences sector. Established in 2010, the firm aims to address societal challenges such as increasing life expectancy and rapid population growth, particularly in Asia and Africa. Their investment strategy targets startups with revolutionary potential in medical diagnostics and therapeutics. Beyond financial support, Mey Capital Matrix provides management expertise and insights, distinguishing itself from traditional investors by adopting an entrepreneurial approach. The team comprises experts with extensive experience in business management and startup consulting, assisting promising companies in achieving their goals.
Is Mey Capital Matrix the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Mey Capital Matrix, along with a list of other relevant VCs, is available on Hopohopo.io.
Stages
Series B or later
First ticket size
€100,000 - €1,500,000
When approaching Mey Capital Matrix, founders should highlight how their solution addresses large-scale, unmet needs in global health, especially those relevant to emerging markets. Emphasize the scalability and transformative impact of your technology, and be prepared to discuss both the scientific rigor and the commercial pathway. Demonstrating a clear plan for regulatory navigation and market entry, as well as openness to leveraging hands-on operational guidance, will resonate with their entrepreneurial, partnership-driven style.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.